Targeting CD43 optimizes cancer immunotherapy through reinvigorating antitumor immune response in colorectal cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Targeting CD43 optimizes cancer immunotherapy through reinvigorating antitumor immune response in colorectal cancer

Published:2023-03-15 Issue:3 Volume:46 Page:777-791
ISSN:2211-3428
Container-title:Cellular Oncology
language:en
Short-container-title:Cell Oncol.

Author:

Li Yi-yi,Wang Xin-yu,Li Yan,Wang Xiu-mei,Liao Jing,Wang Ying-zhao,Hong Hai,Yi Wei,Chen Jun

Funder

Guangdong Basic and Applied Basic Research Foundation of China

Guangzhou Science and Technology Project of China

Grant from MOE Key Laboratory of Gene Function and Regulation

National Natural Science Foundation of China

National Key R&D Program of China

Guangdong project

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,Molecular Medicine,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s13402-023-00794-w.pdf

Reference60 articles.

1. J.Q. Chen, W.H. Zhan, Y.L. He, J.S. Peng, J.P. Wang, S.R. Cai, J.P. Ma, Expression of heparanase gene, CD44v6, MMP-7 and nm23 protein and their relationship with the invasion and metastasis of gastric carcinomas. World J. Gastroenterol. 10, 776–782 (2004)

2. R.L. Siegel, K.D. Miller, H.E. Fuchs, A. Jemal, Cancer statistics, 2022. CA Cancer J. Clin. 72, 7–33 (2022)

3. R.M. McQuade, V. Stojanovska, J.C. Bornstein, K. Nurgali, Colorectal Cancer chemotherapy: the evolution of treatment and New Approaches. Curr. Med. Chem. 24, 1537–1557 (2017)

4. E. Picard, C.P. Verschoor, G.W. Ma, G. Pawelec, Relationships between Immune Landscapes, genetic subtypes and responses to Immunotherapy in Colorectal Cancer. Front. Immunol. 11, 369 (2020)

5. Y. Jiang, Z. Liu, F. Xu, X. Dong, Y. Cheng, Y. Hu, T. Gao, J. Liu, L. Yang, X. Jia, H. Qian, T. Wen, G. An, Aberrant O-glycosylation contributes to tumorigenesis in human colorectal cancer. J. Cell. Mol. Med. 22, 4875–4885 (2018)

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identification and analysis of key genes related to efferocytosis in colorectal cancer;BMC Medical Genomics;2024-08-06

2. HVEM in acute lymphocytic leukemia facilitates tumour immune escape by inhibiting CD8+ T cell function;Cellular Oncology;2024-05-29

3. Ginsenoside Rh2 augmented anti-PD-L1 immunotherapy by reinvigorating CD8+ T cells via increasing intratumoral CXCL10;Pharmacological Research;2023-12

4. Identification of novel targets for immunotherapies in subsets of patients with diffuse large B‐cell lymphoma (DLBCL);British Journal of Haematology;2023-11-14

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3